FdaApplication

NDA 205645

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeNDA
approval_date2016-12-01

Products (1)

ProductActive ingredientStrengthDosage form
TIGECYCLINETIGECYCLINE50MG/VIALPOWDER;INTRAVENOUS

1 product